Real-time data improves visibility and speeds up issue detection, reducing downtime and delays. Live metrics enable faster, more effective production decisions and help optimize performance on the ...

Google has documented a native way to link Google Business Profile to Google Analytics. Once linked, local metrics like calls and direction requests appear in a new section of your reports. If you ...

Local lawmakers are pushing to restrict large-scale data centers amid mounting concern over environmental impacts and backlash tied to Elon Musk’s xAI operation in Memphis. A new bill proposed by ...

AT&T has announced the offering of a new plan that will let subscribers slot in different add-ons on a month-to-month basis. Officially called the ‘Build-A-Plan’, AT&T subscribers will be able to ...

See more of our coverage in your search results.Encuentra más de nuestra cobertura en los resultados de búsqueda. Add The New York Times on GoogleAgrega The New York Times en Google The federal ...

Schema markup is far more common on pages cited by AI. But a new Ahrefs report found that adding it didn’t result in a clear increase in citations. Ahrefs tracked 1,885 web pages that added JSON-LD ...

Abstract: This paper discusses the process of creating a virtual classroom platform. The main goal of this platform is to provide students and teachers uninterrupted learning experiences. React JS is ...

WHITE OAK, MD – The US Food and Drug Administration (FDA) has announced plans for a future pilot program intended to facilitate the real-time review of clinical trials by regulators, as well as the ...

WASHINGTON, April 28 (Reuters) - The U.S. Food and Drug Administration launched a pilot program on Monday aimed at allowing the ‌agency to monitor clinical trial data in real time, a step the agency ...

On a press call, FDA Commissioner Marty Makary, M.D., highlighted the potential for FDA staff to keep up with trials as they are happening and potentially make regulatory decisions without having to ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.